Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 19
Selected: 0
NCT IDTitle
NCT00666601Microdialysis and Pharmacokinetic Study of TR-701
NCT01623401A Phase 1, Open-Label, 10 Day Safety Study
NCT01461460A Thorough QT Study of TR-701free Acid (FA) in Healthy Subjects
NCT00671814Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy Adults
NCT01170221TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
NCT00983255Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)
NCT00876655Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of Torezolid Phosphate
NCT00671359Food Effects of Single Oral Dose of 600mg TR-701
NCT01539473A Phase 1 TR-701 FA Study of Blood Pressure Response Post Tyramine Challenge
NCT01577459A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response
NCT01442831Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
NCT00761215Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
NCT01519778A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study
NCT01156077Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients
NCT01452828A Pharmacokinetics and Safety Study in Subjects With Renal Impairment
NCT01421511TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
NCT01271998Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg
NCT01496677Pharmacokinetics, Safety, and Tolerability of TR-701 Free Acid (FA) in Elderly Subjects
NCT01431833A PK and Safety Study in Subjects With Hepatic Impairment